Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/27/20 4 Saenger Bradley 2
02/27/20 4 Morris Jessica Edgar 2
02/26/20 8-K Current report filing
Related Documents
6
02/18/20 SEC STAFF LETTER 1
02/14/20 5 Saenger Bradley 2
02/14/20 5 Sullivan Gregory M 2
02/14/20 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
02/14/20 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 10
02/14/20 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 6
02/14/20 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
RSS